EI
TMDX icon

Ellevest Inc’s Transmedics TMDX Stock Holding History

Ellevest Inc’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$2.27K – 1501
2023
Q1 		$2.27K Buy
30
+11
+58% +$761 ﹤0.01% 1422
2022
Q4 		$1.17K Buy
19
+11
+138% +$585 ﹤0.01% 1487
2022
Q3 		$0 Buy
+8
New +$348 ﹤0.01% 1858

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Ellevest Inc's TMDX Position: Q2 2023 in Review

Ellevest Inc sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 30 shares — an estimated $2.27K sold.

Ellevest Inc first reported a position in TMDX in Q3 2022 and held it in 3 quarters. The position peaked at $2.27K in Q1 2023. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

  • Ellevest Inc reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 30 Transmedics shares in Q2 2023, an estimated $2.27K.
  • Ellevest Inc first reported a position in Transmedics in Q3 2022 and held it in 3 quarters.
  • Ellevest Inc's Transmedics position peaked at $2.27K in Q1 2023.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.